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PhaB (acetoacetyl-CoA reductase) catalyzes the reduction of acetoacetyl-CoA to (R)-3-
hydroxybutyryl-CoA in polyhydroxybutyrate (PHB) synthesis and FabG (3-ketoacyl-acyl-carrier-
protein reductase) catalyzes the b-ketoacyl-ACP to yield (R)-3-hydroxyacyl-ACP in fatty acid
biosynthesis. Both of them have been classified into the same group EC 1.1.1. PhaB is limited with
substrate specificities, while FabG was considered as a potential PhaB due to broad substrate
selectivity despite of low activity. Here, X-ray crystal structures of FabG and PhaB from the
photosynthetic microorganism Synechocystis sp. PCC 6803 were resolved. Based on them, a high-
performance FabG on acyl-CoA directed by structural evolution was constructed that may serve as
a critical enzyme to partition carbon flow from fatty acid synthesis to PHA.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Polyhydroxyalkanoate (PHA) is a potentially new generation
material that can substitute for traditional plastics and is synthe-
sized by many microorganisms as an energy storage compound.
PHAs include poly(3-hydroxybutyrate-co-4-hydroxybutyrate), pol
y(3-hydroxybutyrate-co-3-hydroxyvalerate) and poly(3-hydroxy
butyrate-co-lactate) and are produced by engineered microorgan-
isms [1–4]. However, PHA production is challenging because it is
difficult to vary the monomer composition of the copolymers,
and a key concern is using carbohydrates as the carbon source con-
verted to PHA by heterotrophic microorganisms. Cyanobacteria,
which can use sunlight and CO2 as energy and carbon sources,
respectively, to synthesize PHAs, have become an attractive
‘‘microbial factory” for producing renewable biofuels and green
chemicals [5–9]. Therefore, it is critical to investigate the optimiza-
tion of PHAs synthesis from cyanobacteria.In the cyanobacterium Synechocystis sp. PCC 6803, PHA exists
predominantly in the form of poly-3-hydroxybutyrate (PHB) [10].
PHB synthesis requires three steps. First, acetoacetyl-coenzyme A
(acetoacetyl-CoA) thiolase PhaA (EC 2.3.1.9) catalyzes a reaction
in which two molecules of acetyl-CoA are used to form
acetoacetyl-CoA. Next, acetoacetyl-CoA reductase (PhaB) (EC
1.1.1.36) catalyzes NADPH-dependent reduction of acetoacetyl-
CoA to yield D-(b)-3-hydroxybutyryl-CoA. Finally, PHA synthase
catalyzes D-(b)-3-hydroxybutyryl-CoA polymerization to form
PHB [11]. Medium chain length (R)-3-hydroxyacyl-CoAs (mcl-
PHAs), which include monomers that are C6–C14 long, can be
obtained from intermediates of fatty acid de novo synthesis and
fatty acid b-oxidation, while it is found only in certain hetero-
trophic bacteria [12–15]. The 3-ketoacyl-acyl-carrier-protein
reductase (FabG) (EC 1.1.1.100) catalyzes NADPH-dependent
b-ketoacyl-ACP reduction, which produces the (R)-3-
hydroxyacyl-ACP involved in fatty acid biosynthesis [16]. FabG
exhibits especially broad specificity toward 3-ketoacyl-ACP with
C4 to C10 as well as toward 3-ketoacyl-CoA. Both PhaB and FabG
belong to the same EC 1.1.1. group, the constituents of which
reduce ketonic groups to hydroxy groups; however, the former
functions on compounds with CoA while the latter does on the
ACP form. Notably, both substrates include the phosphopanteth-
eine portion and an acyl head (Fig. 1), which suggests that the
functions of these two enzymes may overlap, and the substrate
Fig. 1. A comparison of SpFabG and SpPhaB substrates. Acetoacetyl coenzyme A is above, and acetoacetyl-ACP is below. Both substrates consist of the phosphopantetheine
portion and an acyl head. Further, the acetoacetyl-ACP head can be altered by acyl-ACP.
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Previous studies confirm that FabG can play the role of PhaB with
lower activity [17,18]. Furthermore, Escherichia coli FabG can
reduce the mcl-3-ketoacyl-CoAs generated by b-oxidation to 3-
hydroxyacyl-CoAs and provide precursors for PHA synthesis [19].
Therefore, there exists a great opportunity to construct a high-
performance FabG as an alternative to acyl-CoA reductase to
enhance PHB production and provide (R)-3-hydroxyacyl-CoAs for
mcl-PHA biosynthesis to redirect carbon flow from fatty acid syn-
thesis to PHA.
This is the first report on the crystal structures of SpFabG and
SpPhaB from the photosynthetic microorganism Synechocystis sp.
PCC 6803. Comparing the structures for SpFabG and SpPhaB led
us to design a high-performance FabG through mutation, which
could enhance acetoacetyl-CoA reduction efficiency. The results
of this study provide a new theoretical foundation for producing
mcl-PHAs from Synechocystis sp. PCC 6803 that use sunlight and
CO2 as energy and carbon sources.
2. Methods and materials
2.1. Gene cloning, protein expression and purification
The E. coli strains DH5a and BL21 were used for DNA cloning.
Molecular manipulations were performed using standard methods.
The full length SpFabG and SpPhaB were amplified using DNA from
Synechocystis sp. PCC 6803 as a template with the following
primers:
FabG forward: 50-CATATGACGGCATTAACGG-30,
FabG rearward: 50-CTCGAGTTAGAACATTACCATG-30,
PhaB forward: 50-CATATGTTAAGTCTTGGTTTGG-30, and
PhaB rearward: 50-CTCGAGTTAGGTGTGGTGGGCCCC-30.
The NdeI and XhoI restriction enzyme sites in the forward and
reverse primers are underlined. The PCR product was digested by
NdeI and XhoI, and the product was purified and cloned into the
pColdII vector. Finally, the recombinant plasmids were trans-
formed into E. coli BL21 (DE3) competent cells.
To induce the recombinant protein, 0.5 mM isopropyl b-D-1-
thiogalactopyranoside (IPTG) was added to cells previously grown
to an OD600 of 0.5 at 37 C in LB medium containing 50 lg/mLampicillin. The cells were further grown at 16 C for 6 h and 18 h
for SpFabG and SpPhaB, respectively, before they were harvested
by centrifugation at 6500g for 20 min at 4 C. The cell pellet
was then suspended in lysis buffer (50 mM Na-phosphate pH 8.0,
300 mM NaCl, 5% glycerol (v/v), and 2 mM b-mercaptoethanol)
and homogenized using ultrasonication on ice. The lysate was cen-
trifuged for 30 min at 12000g at 4 C. The supernatant containing
the soluble SpFabG and SpPhaB proteins was then added to
Ni–NTA resin (Qiagen) as described by Liu et al. [20], and the eluted
proteins were further purified on a superdex 200 column by ÄKTA
prime plus (GE) equilibrated with Tris–HCl buffer (50 mM Tris–HCl
pH 7.8, 300 mM NaCl, 1 mM EDTA, 5% glycerol (v/v), and 2 mM
b-mercaptoethanol). The fractions containing SpFabG and SpPhaB
were concentrated using an Amicon concentrator 10kDa (Milli-
pore), and the protein concentrations were determined using the
Bradford assay with BSA as the standard. Finally, SpFabG and
SpPhaB were stored at 80 C prior to crystallization.
2.2. Protein crystallization
A diffraction-quality crystal of SpFabG was obtained at 289 K by
mixing 1.5 lL reservoir solution consisting of 0.14 M Li2SO4, 0.1 M
Tris–HCl pH 8.5, and 20% (w/v) PEG4000 with an equal volume of
5 mg/mL of the protein solution, which contained 50 mM Tris–HCl
pH 7.8, 150 mM NaCl, 5% (v/v) glycerol, 1 mM EDTA, and 2 mM b-
mercaptoethanol, using the hanging-drop method. The crystals
typically exhibited a diamond shape. The cryo-protectant solution
of SpFabG was the mother solution plus 15% glycerol. Additionally,
a diffraction-quality crystal of SpPhaB was obtained at 277 K by
mixing 1.5 lL reservoir solution consisting of 0.22 M magnesium
acetate, 0.1 M sodium cacodylatertrihydrate pH 6.5, and 18%
(w/v) PEG8000 with an equal volume of 10 mg/mL of the protein
solution, which contained 50 mM Tris–HCl pH 7.8, 300 mM NaCl,
5% (v/v) glycerol, 0.5 mM EDTA, and 2 mM b-mercaptoethanol,
using the hanging-drop method. For cryo-protection, the crystals
were soaked in buffers containing the mother liquid with 20%
glycerol.
2.3. Data collection and structure determination
Diffraction data for the SpFabG and SpPhaB crystals were col-
lected at 100 K using a beamline BL17U1 at the Shanghai Syn-
chrotron Radiation Facility. All data sets were processed using
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were determined using molecular replacement and the structure of
E. coli FabG (PDB accession No. 1Q7B) as an initial search model.
The preliminary models were refined using the Phenix program
[22], and the residue positions were manually adjusted in COOT
[23]. The data collected and refinement statistics are summarized
in Supplemental Table S1. The models were visualized and ana-
lyzed using Pymol. The atomic coordinates have been deposited
in the PDB database with the ID 4RZH for SpFabG and the ID
4RZI for SpPhaB.
2.4. Point mutations and enzyme activity experiments
Point mutations were created using the PrimeSTAR DNA Poly-
merase (TAKARA, Japan), and sequencing was performed to con-
firm that the correct mutation was incorporated. The mutant
proteins were purified by the same method as the wild type. The
enzyme activities of the wild type and mutant proteins were mea-
sured by monitoring the decrease in absorbance at 340 nm (Jasco
V630 spectrophotometer, Japan) as NADPH is converted to NADP+.
The reaction mixture (200 lL) contained 50 mM Tris–HCl pH 7.8,
300 mM NaCl, 5 mM EDTA, 0.2 mM NADPH and 0.2 mM
acetoacetyl-CoA. For each reaction, 0.9 lg of the wild-type or
mutant FabG protein was added to initiate the reaction, and the
decrease in absorbance at 340 nm was monitored at room temper-
ature for 5 min. The error bars denote standard deviations from the
mean value for three independent reactions.
3. Results and discussion
3.1. Crystal structure of SpFabG and SpPhaB
The SpFabG structure was determined using molecular replace-
ment and refined to the Rwork and Rfree values 0.17 and 0.21, and
SpPhaB was refined the Rwork and Rfree values 0.20 and 0.24,
respectively (Fig. 2). The overall structures of these two proteins
were essentially the same, and both belong to the short-chain
dehydrogenase/reductase (SDR) family of NADPH-dependent oxi-
doreductases consisting of seven b-sheets and eight a-helices.Fig. 2. Crystal structures of SpFabG and SpPhaG. (A) An overall perspective of SpFabG. Th
are in gray. A flexible region corresponding to 190–200 of SpFabG was not observed in th
SpPhaB. The a helices are colored in green, the b strands are in red, and the coil regions a
The amino and carboxyl termini are labeled N-terminal and C-terminal, respectively.The central b-sheet adopted a b7b6b5b4b1b2b3 topology and
packed against helices a1, a2, and a8 on one side, and against
helices a3, a4, and a5 on the other side. Further, superposition
of SpPhaB and SpFabG yielded an RMSD of 0.559 Å, which consid-
ers 183 Ca atoms (Fig. 3A).
SDR proteins typically include a conserved catalytic triad com-
posed of S143, Y156 and K160, which was confirmed in SpFabG,
while the PhaB active center has not been reported. Considering
the structural similarity, we proposed a catalysis triad consisting
of S134, Y147 and K151 in SpPhaB, in contrast to SpFabG in Fig. 4.
It was verified by mutagenesis experiments. The K151A mutant of
SpPhaB exhibited a decrease in AcAcCoA reductive activity to 12%,
while the S134A mutant exhibited a decreased to 5%; moreover,
the Y147A mutant showed undetectable activity (Fig. 3B).
Combining the PhaB structure and the SDR reductase catalysis
process, proton transfer occurs from the active Y residue of the
enzyme to the carbonyl oxygen of the substrate, and the conserved
S134 residue is thought to aid in stabilizing the substrates. The
other conserved K151 exhibits two functions, providing hydrogen
bond interactions with the nicotinamideribosyl moiety of the
cofactor and lowering the pKa of the proton on the catalytic Y
through ionic interactions.
Although the overall structure and catalysis core were highly
analogous, some differences between SpPhaB and SpFabG can also
be found. The most striking difference emerged at the region
between residues 190 and 200 of SpFabG which it was poorly
observed and exhibited a flexible region, while the corresponding
region in SpPhaB exhibited an a-helix shape (Fig. 3A). Based on a
comparison with the E. coli FabG in complex with NADP+ (PDB ID
1Q7B) structure, the region was considered a substrate-binding
lid. The differences between SpFabG and SpPhaB might account
for their respective substrate selectivities; the flexible region of
SpFabG may facilitate substrate accessibility with AcAc-ACP as a
larger molecule, whereas the a-helix of SpPhaB might narrow the
substrate size to a much smaller AcAc-CoA. Such observations
may provide a foundation for constructing a high-performance
FabG using acyl-CoA through structure-directed evolution, which
is discussed below in detail.e a helices are colored in green, the b strands are colored in red, and the coil regions
e electron density map and is indicated by dotted lines. (B) An overall perspective of
re in gray. The catalytic triads with S134, Y147 and K151 are shown as stick figures.
Fig. 3. A comparison of the structure and catalytic triad for SpFabG and SpPhaB. (A) Structure superposition of SpFabG (green) and SpPhaB (cyan); the flexible lid region of
SpFabG was not observed. (B) Enzymatic assay using SpPhaB and its catalytic triad mutants (S134A, Y147A and K151A). The activity of SpPhaB was defined as 1, and the
relative activities of the catalytic triad mutants were compared with SpPhaB.
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alternative SpPhaB
Based on the enzyme activity analysis, SpFabG exhibited 6.2-
fold lower activity relative to SpPhaB when acetoacetyl coenzyme
A was used as a substrate (Fig. 6). A surface analysis of the SpFabG/
SpPhaB structures shows a deep cleft (Supplemental Fig. S1) com-
posed of two components, the substrate binding region and the
cofactor NADPH binding region, which should be critical to their
different substrate activities.
The nicotinamide portion of NADPH is buried in the active site
cavity proximal to the S-Y-K triad, and the adenine ring of NADPH
fits into a hydrophobic pocket on the surface of the enzymes. The
pyrophosphate moiety is located between b1 and a1, which con-Fig. 4. Multiple sequence alignments for FabG and PhaB with their orthologous enzyme
boxed in green. The catalytic triad is labeled with a purple rectangle below. The critical stains the SDR motif ‘TGXXXGXG’; however, the pyrophosphate
moiety interactions varied among the SDR enzymes. As shown in
Fig. 4, the NADPH binding cleft contains two regions colored with
cyan boxes. In each FabG enzyme, the A14 was extremely con-
served, while the corresponding residue in PhaB was glycine. Con-
sidering that the glycine may function to allow unconstrained
folding to bind the cofactor, site-directed mutation was performed
on SpFabG to observe the A14G mutant activity. As expected, a 4.2-
fold increase in activity was observed, which demonstrates that
NADPH is important for binding and functioning in PhaB.
Thus far, the PhaB structure was only studied in Ralstonia
eutropha, and the acetoacetyl coenzyme A binding region had been
identified. The substrate binding sites located near the active center
involve two regions located at the end of b5 and b6, respectively. Ass. The NADPH-binding region is boxed in cyan, and the substrate binding region is
ites involved in enzyme activity in this paper are labeled with a blue triangle below.
Fig. 5. Structure-based directional evolution of FabG to PhaB. (A) Position 151 of SpFabG is generally represented by valine or phenylalanine, which may facilitate
hydrophobic interactions with acetoacetyl-CoA. (B) Position 188 in SpFabG is mostly occupied by phenylalanine, while a mutation to tyrosine provides a hydrogen bond
interaction with the substrate. The figures were generated using PYMOL with different perspectives for visual observation. The comparison model is RePhaB (PDB ID:3VZS) in
complex with acetoacetyl-CoA.
Fig. 6. Activity assays of SpPhaB, SpFabG and its mutants toward acetoacetyl-CoA.
The data are the means ± SD (n = 3). The activity of SpPhaB was defined as 1, and the
relative activities of the mutants were compared with SpPhaB.
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rectangles, with the first region is related to the catalytic core, and
the second refers to a clamp-lid region.
At the region near the catalysis core, P151 was observed in
SpFabG, whereas, in PhaB, it was occupied by F or V (Fig. 4), which
provided stronger hydrophobic interactions with the adenine ring
of the specific CoA moiety (Fig. 5A). Based on the structural find-
ings, to specifically enhance the interaction between SpFabG and
acyl-CoA, SpFabG P151V and P151F point mutations were gener-
ated. They give rise to improved enzyme activities of 5.67-fold
and 2.76-fold. And the active center residue FabG K160A mutation
lost most of its activity as a negative. In SpFabG, the potential sub-
strate binding site was located adjacent to F188, which is similar to
SpPhaB. However, in certain species, such as RePhaB, the corre-
sponding residue is occupied by tyrosine, the hydroxyl group of
which forms a stable hydrogen bond with the carbonyl group of
the pantothenate moiety of AcAcCoA (Fig. 5B), which exhibits a
better interaction with the substrate. Correspondingly, the SpFabG
F188Y mutant exhibited 3.36-fold enhanced enzyme activity.
In RePhaB, R195 was considered a critical residue because it
participates in the clamp-lid movement, and its NH1 and NH2
are bound to the two phosphate groups of AcAcCoA through chargeinteractions [24]. The corresponding site in FabG is non-polar
amino acids (A) or uncharged polar amino acids (N or S), which
may hinder substrate entry. When SpFabG N198 was mutated to
R, the relative reducibility of FabG_N198R mutant toward AcAcCoA
increased 3.48-fold. In order to further enhance AcAcCoA reductase
activity in SpFabG, a double point mutation was constructed. How-
ever, it displayed activity similar to FabG_F188Y and 25% less
activity than FabG_N198R (Fig. 6). Y188 is located inside the
enzyme, and R198 is on the surface. It is unclear why the double
mutant had the lowered activity.
4. Conclusion
Constructingahigh-performance FabG is apromisingapplication
for enhanced PHB and medium-chain-length PHA (mcl-PHA) syn-
thesis. In this study, crystal structures of SpFabG and SpPhaB from
the same species, Synechocystis sp. PCC 6803 were determined.
Structural and enzyme activity analyses revealed less restrained
cofactor binding, enhanced hydrogen bond and hydrophobic inter-
actions, plus positive charge around substrate binding cleft could
be specificity for PhaB. Next, high-performance FabG mutants for
acyl-CoA were successfully constructed through directed structural
evolution. These may shed new light on the structural evolution of
PhaB and provide a new theoretical foundation for producing
mcl-PHA from Synechocystis sp. PCC 6803 that utilizes sunlight and
CO2 as energy and carbon sources.
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